Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-30, Stock:LLY, The news for the past five days is as follows:
2018-10-23: NEWS1: Pfizer-Lilly non-opioid drug helps reduce osteoarthritis pain.NEWS2: Complete Results from First Study in Ongoing Phase 3 Program for Tanezumab Demonstrated Significant Improvement in Pain and Function in Osteoarthritis Patients.NEWS3: This IBD Stock Of The Day Is Heading For Fourth Quarter Of Profitability.NEWS4: Notable ETF Inflow Detected - XLV, LLY, BMY, CVS.NEWS5: Notable ETF Inflow Detected - XLV, LLY, BMY, CVS.NEWS6: How Is Novartis Valued?.NEWS7: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS8: Investor Expectations to Drive Momentum within Navios Maritime Partners LP, Alliance Data, Eli Lilly, CONVERGEONE HLD, Atkore International Group, and NantKwest — Discovering Underlying Factors of Influence.NEWS9: Why Nektar Therapeutics Crashed 17.2% Today.NEWS10: Why Nektar Therapeutics Crashed 17.2% Today.
2018-10-24: NEWS1: Incyte (INCY) to Report Q3 Earnings: What's in the Cards?.NEWS2: Incyte (INCY) to Report Q3 Earnings: What's in the Cards?.NEWS3: Pfizer Succeeds in Pain Study, Forms JV to Make CNS Drugs.NEWS4: Pfizer Succeeds in Pain Study, Forms JV to Make CNS Drugs.NEWS5: Recommendations for Allergan on October 24.NEWS6: Pfizer Succeeds in Pain Study, Forms JV to Make CNS Drugs.NEWS7: New pain drug from Pfizer and Eli Lilly shows promise as opioid alternative.NEWS8: Pfizer-Lilly non-opioid drug helps reduce osteoarthritis pain.NEWS9: CMTA Fast Tracks NDA Filing, USNA In Good Health, DERM To Report Data In Apr..NEWS10: CMTA Fast Tracks NDA Filing, USNA In Good Health, DERM To Report Data In Apr..
2018-10-25: NEWS1: Eli Lilly Is Just Taking a Normal Pause.NEWS2: Merck (MRK) Beats on Q3 Earnings, Lags Sales, Ups EPS View.NEWS3: Merck (MRK) Beats on Q3 Earnings, Lags Sales, Ups EPS View.NEWS4: How JNJ’s Invega Sustenna and Risperdal Consta Performed.NEWS5: Analysts See 10% Gains Ahead For DVOL.NEWS6: Analysts See 10% Gains Ahead For DVOL.NEWS7: Merck says to retain animal health business as part of company.NEWS8: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS9: Today's Research Reports on Trending Tickers: AstraZeneca and Eli Lilly and Company.
2018-10-26: NEWS1: How Is JNJ’s Cardiovascular & Metabolism Business Positioned?.NEWS2: See what the IHS Markit Score report has to say about Eli Lilly And Co..
2018-10-29: NEWS1: Biogen And Eisai May Be At Odds In Alzheimer's — So What Now?.NEWS2: Dicerna Soars After Eli Lilly Invests $100M In Licensing, Research Deal.NEWS3: Dicerna&apos;s stock rockets after licensing, research collaboration with Eli Lilly.NEWS4: Eli Lilly makes bet on gene-silencing drug firm Dicerna.NEWS5: Lilly and Dicerna Announce RNAi Licensing and Research Collaboration.NEWS6: Drug giant Lilly backs Cambridge&apos;s Dicerna in $200M deal.NEWS7: Dicerna Stock Surges On RNAi Deal With Lilly.NEWS8: Dicerna Stock Surges On RNAi Deal With Lilly.NEWS9: [$$] Follow the FDA’s Self-Interest.

Answer: Rise